Literature DB >> 23571360

Risk of acquiring extended-spectrum β-lactamase-producing Klebsiella species and Escherichia coli from prior room occupants in the intensive care unit.

Adebola O Ajao1, J Kristie Johnson, Anthony D Harris, Min Zhan, Jessina C McGregor, Kerri A Thom, Jon P Furuno.   

Abstract

OBJECTIVE. To quantify the association between admission to an intensive care unit (ICU) room most recently occupied by a patient positive for extended-spectrum β-lactamase (EBSL)-producing gram-negative bacteria and acquisition of infection or colonization with that pathogen. DESIGN. Retrospective cohort study. SETTING AND PATIENTS. The study included patients admitted to medical and surgical ICUs of an academic medical center between September 1, 2001, and June 30, 2009. METHODS. Perianal surveillance cultures were obtained at admission to the ICU, weekly, and at discharge from the ICU. Patients were included if they had culture results that were negative for ESBL-producing gram-negative bacteria at ICU admission and had an ICU length of stay longer than 48 hours. Pulsed-field gel electrophoresis (PFGE) was performed on ESBL-positive isolates from patients who acquired the same bacterial species (eg, Klebsiella species or Escherichia coli) as the previous room occupant. RESULTS. Among 9,371 eligible admissions (7,651 unique patients), 267 (3%) involved patients who acquired an ESBL-producing pathogen in the ICU; of these patients, 32 (12%) were hospitalized in a room in which the prior occupant had been positive for ESBL. Logistic regression results suggested that the prior occupant's ESBL status was not significantly associated with acquisition of an ESBL-producing pathogen (adjusted odds ratio, 1.39 [95% confidence interval, 0.94-2.08]) after adjusting for colonization pressure and antibiotic exposure in the ICU. PFGE results suggested that 6 (18%) of 32 patients acquired a bacterial strain that was the same as or closely related to the strain obtained from the prior occupant. CONCLUSIONs. These data suggest that environmental contamination may not play a substantial role in the transmission of ESBL-producing pathogens among ICU patients. Intensifying environmental decontamination may be less effective than other interventions in preventing transmission of ESBL-producing pathogens.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23571360      PMCID: PMC3660030          DOI: 10.1086/670216

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  31 in total

1.  Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms.

Authors:  Jessina C McGregor; Peter W Kim; Eli N Perencevich; Douglas D Bradham; Jon P Furuno; Keith S Kaye; Jeffrey C Fink; Patricia Langenberg; Mary-Claire Roghmann; Anthony D Harris
Journal:  Am J Epidemiol       Date:  2005-03-01       Impact factor: 4.897

2.  Test characteristics of perirectal and rectal swab compared to stool sample for detection of fluoroquinolone-resistant Escherichia coli in the gastrointestinal tract.

Authors:  Ebbing Lautenbach; Anthony D Harris; Eli N Perencevich; Irving Nachamkin; Pam Tolomeo; Joshua P Metlay
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

3.  Molecular epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated from environmental and clinical specimens in a cardiac surgery intensive care unit.

Authors:  Guillaume Kac; Isabelle Podglajen; Sabine Vaupré; Nathalie Colardelle; Annie Buu-Hof; Laurent Gutmann
Journal:  Infect Control Hosp Epidemiol       Date:  2004-10       Impact factor: 3.254

4.  The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable.

Authors:  M J Bonten; S Slaughter; A W Ambergen; M K Hayden; J van Voorhis; C Nathan; R A Weinstein
Journal:  Arch Intern Med       Date:  1998-05-25

Review 5.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

6.  Prediction rules to identify patients with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci upon hospital admission.

Authors:  Jon P Furuno; Anthony D Harris; Marc-Oliver Wright; Jessina C McGregor; Richard A Venezia; Jingkun Zhu; Eli N Perencevich
Journal:  Am J Infect Control       Date:  2004-12       Impact factor: 2.918

7.  Identifying groups at high risk for carriage of antibiotic-resistant bacteria.

Authors:  Jon P Furuno; Jessina C McGregor; Anthony D Harris; Judith A Johnson; Jennifer K Johnson; Patricia Langenberg; Richard A Venezia; Joseph Finkelstein; David L Smith; Sandra M Strauss; Eli N Perencevich
Journal:  Arch Intern Med       Date:  2006-03-13

Review 8.  Extended-spectrum beta-lactamases and clinical outcomes: current data.

Authors:  Reuben Ramphal; Paul G Ambrose
Journal:  Clin Infect Dis       Date:  2006-04-15       Impact factor: 9.079

9.  Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital.

Authors:  R Ben-Ami; M J Schwaber; S Navon-Venezia; D Schwartz; M Giladi; I Chmelnitsky; A Leavitt; Y Carmeli
Journal:  Clin Infect Dis       Date:  2006-02-27       Impact factor: 9.079

10.  The molecular and clinical epidemiology of enterobacteriaceae-producing extended-spectrum beta-lactamase in a tertiary care hospital.

Authors:  E D'Agata; L Venkataraman; P DeGirolami; L Weigel; M Samore; F Tenover
Journal:  J Infect       Date:  1998-05       Impact factor: 6.072

View more
  9 in total

1.  Carbapenem-Resistant Enterobacteriaceae: Laboratory Detection and Infection Control Practices.

Authors:  Eva-Brigitta Kruse; Ute Aurbach; Hilmar Wisplinghoff
Journal:  Curr Infect Dis Rep       Date:  2013-10-12       Impact factor: 3.725

2.  Carbapenem MICs in Escherichia coli and Klebsiella Species Producing Extended-Spectrum β-Lactamases in Critical Care Patients from 2001 to 2009.

Authors:  J Kristie Johnson; Gwen L Robinson; Lisa L Pineles; Adebola O Ajao; LiCheng Zhao; Jennifer S Albrecht; Anthony D Harris; Kerri A Thom; Jon P Furuno
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

Review 3.  Transmission of health care-associated infections from roommates and prior room occupants: a systematic review.

Authors:  Bevin Cohen; Catherine Crawford Cohen; Borghild Løyland; Elaine L Larson
Journal:  Clin Epidemiol       Date:  2017-05-23       Impact factor: 4.790

Review 4.  Antibiotic stewardship and horizontal infection control are more effective than screening, isolation and eradication.

Authors:  S W Lemmen; K Lewalter
Journal:  Infection       Date:  2018-05-23       Impact factor: 3.553

5.  Relevance of intra-hospital patient movements for the spread of healthcare-associated infections within hospitals - a mathematical modeling study.

Authors:  Hannan Tahir; Luis Eduardo López-Cortés; Axel Kola; Dafna Yahav; André Karch; Hanjue Xia; Johannes Horn; Konrad Sakowski; Monika J Piotrowska; Leonard Leibovici; Rafael T Mikolajczyk; Mirjam E Kretzschmar
Journal:  PLoS Comput Biol       Date:  2021-02-03       Impact factor: 4.475

6.  Predictors of hospital surface contamination with Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: patient and organism factors.

Authors:  Joshua T Freeman; Jessica Nimmo; Eva Gregory; Audrey Tiong; Mary De Almeida; Gary N McAuliffe; Sally A Roberts
Journal:  Antimicrob Resist Infect Control       Date:  2014-02-04       Impact factor: 4.887

7.  The impact of antibiotic use on transmission of resistant bacteria in hospitals: Insights from an agent-based model.

Authors:  Jonatan Almagor; Elizabeth Temkin; Itzhak Benenson; Noga Fallach; Yehuda Carmeli
Journal:  PLoS One       Date:  2018-05-14       Impact factor: 3.240

8.  Extended-Spectrum Beta-lactamase Producers: Detection for the Diagnostic Laboratory.

Authors:  Rani Diana Sahni; Dilip Mathai; Thambu David Sudarsanam; V Balaji; K N Brahamadathan; Mary V Jesudasan; M K Lalitha
Journal:  J Glob Infect Dis       Date:  2018 Jul-Sep

9.  [Clinical significance and risk factors for multidrug resistant Enterobacteriaceae colonization].

Authors:  A Padilla-Serrano; J J Serrano-Castañeda; R Carranza-González; M P García-Bonillo
Journal:  Rev Esp Quimioter       Date:  2018-05-04       Impact factor: 1.553

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.